Shaowei Qiu

Shaowei Qiu

Auto-generated profile, based on publicly available information

Shaowei Qiu

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2023 in Blood
Verified
Journal Article
Closed access
PDF file
SQShaowei Qiu
Shaowei Qiu
VSVipul S Sheth
Vipul S Sheth
CYChengcheng Yan
Chengcheng Yan
JLJuan Liu
Juan Liu
BCBalu K. Chacko
Balu K. Chacko
RBRavi Bhatia
Ravi Bhatia
Tyrosine kinase inhibitors (TKIs) are very effective in treating chronic myelogenous leukemia (CML), but primitive, quiescent leukemia stem cells persist as a barrier to the cure. We performed a comprehensive evaluation of metabolic adaptation to TKI treatment and its role in CML hematopoietic stem and progenitor cell persistence. Using a CML mouse model, we found that glycolysis, glutaminolysis, the tricarboxylic acid cycle, and oxidative phosphorylation (OXPHOS) were initially inhibited by TKI treatment in CML-committed progenitors but were restored with continued treatment, reflecting both selection and metabolic reprogramming of specific subpopulations. TKI treatment selectively enriched primitive CML stem cells with reduced metabolic gene expression. Persistent CML stem cells also showed metabolic adaptation to TKI treatment through altered substrate use and mitochondrial respiration maintenance. Evaluation of transcription factors underlying these changes helped detect increased HIF-1 protein levels and activity in TKI-treated stem cells. Treatment with an HIF-1 inhibitor in combination with TKI treatment depleted murine and human CML stem cells. HIF-1 inhibition increased mitochondrial activity and reactive oxygen species (ROS) levels, reduced quiescence, increased cycling, and reduced the self-renewal and regenerating potential of dormant CML stem cells. We, therefore, identified the HIF-1–mediated inhibition of OXPHOS and ROS and maintenance of CML stem cell dormancy and repopulating potential as a key mechanism of CML stem cell adaptation to TKI treatment. Our results identify a key metabolic dependency in CML stem cells persisting after TKI treatment that can be targeted to enhance their elimination.

10 February 2018 in Journal of Hematology & Oncology
Verified
Journal Article
Open access
PDF file
HWHui Wei
Hui Wei
YWYing Wang
Ying Wang
CZChunlin Zhou
Chunlin Zhou
DLDong Lin
Dong Lin
BLBingcheng Liu
Bingcheng Liu
JWJIANXIANG WANG
JIANXIANG WANG
Racial and ethnic disparities in malignancies attract extensive attention. To investigate whether there are racial and ethnic disparities in genetic alteration between Caucasian and Eastern Asian population, data from several prospective AML trials were retrospectively analyzed in this study. We found that there were more patients with core binding factor (CBF) leukemia in Eastern Asian cohorts and there were different CBF leukemia constitutions between them. The ratios of CBF leukemia are 27.7, 22.1, 21.1, and 23.4%, respectively, in our (ChiCTR-TRC-10001202), another Chinese, Korean, and Japanese Eastern Asian cohorts, which are significantly higher than those in ECOG1900, MRC AML15, UK NCRI AML17, HOVON/SAKK AML-42, and German AML2003 (15.5, 12.5, 9.3, 10.2, and 12%, respectively). And CBFbeta-MYH11 occurred more prevalently in HOVON/SAKK AML- 42 and ECOG1900 trials (50.0 and 54.3% of CBF leukemia, respectively) than in Chinese and Japanese trials (20.1 and 20.8%, respectively). The proportion of FLT3-ITD mutation is 11.2% in our cohort, which is lower than that in MRC AML15 and UK NCRI AML17 (24.6 and 17.9%, respectively). Even after excluding the age bias, there are still different incidence rates of mutation between Caucasian and Eastern Asian population. These data suggest that there are racial and ethnic disparities in genetic alteration between Caucasian and Eastern Asian population.

1 September 2013 in Leukemia Research
Verified
Journal Article
Closed access
SWShuning Wei
Shuning Wei
SWSiping Wang
Siping Wang
SQShaowei Qiu
Shaowei Qiu
JQJunyuan Qi
Junyuan Qi
YMYingchang Mi
Yingchang Mi
JWJIANXIANG WANG
JIANXIANG WANG

31 July 2023 in Cancer Communications
Verified
Journal Article
Open access
ZWZhenzhen Wang
Zhenzhen Wang
YLYang Lu
Yang Lu
YLYu Liu
Yu Liu
JMJunli Mou
Junli Mou
XLXiaoyu Liu
Xiaoyu Liu
JWJIANXIANG WANG
JIANXIANG WANG

31 October 2024 in Leukemia
Verified
Journal Article
Closed access
PDF file
SQShaowei Qiu
Shaowei Qiu
YMYihan Mei
Yihan Mei
RGRunxia Gu
Runxia Gu
YLYu Liu
Yu Liu
MCManling Chen
Manling Chen
JWJIANXIANG WANG
JIANXIANG WANG

16 September 2024 in Blood Cancer Journal
Verified
Journal Article
Open access
YLYu Liu
Yu Liu
WLWenbing Liu
Wenbing Liu
ALAnli Lai
Anli Lai
YMYihan Mei
Yihan Mei
YWYing Wang
Ying Wang
SQShaowei Qiu
Shaowei Qiu